Advertisement

Mouse Model for Cholangiocarcinoma from Peribiliary Glands

  • Hayato Nakagawa
  • Nobumi Suzuki
  • Kazuhiko Koike
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1905)

Abstract

A good mouse model is mandatory for elucidating carcinogenic mechanisms and identifying the cellular origin of cancer. Although the lack of an appropriate mouse model has hampered investigation of extrahepatic cholangiocarcinoma (ECC), we recently established a novel mouse model of biliary injury-related ECC by ductal cell-specific activation of Kras and deletion of transforming growth factor (TGF) β receptor type 2 and E-cadherin. Using this mouse model, we identified that peribiliary glands, which are considered a biliary epithelial stem cell niche, are potential cellular origins of ECC. Furthermore, we established an extrahepatic biliary organoid-derived xenograft cholangiocarcinoma (CC) model by lentiviral induction of Cre in organoids. This organoid system recreated the in vivo conditions and facilitated analysis of carcinogenesis. In this chapter, we describe the protocol used to establish our mouse model of ECC derived from peribiliary glands and our extrahepatic biliary organoid-derived xenograft model of CC.

Key words

Extrahepatic cholangiocarcinoma Biliary organoid Peribiliary gland Inflammation E-cadherin 

Notes

Acknowledgments

This study was supported by the Japan Society for the Promotion of Science KAKENHI grant number 15K09039, Astellas Foundation for Research on Metabolic Disorders, Nakayama Cancer Research Institute, Okinaka Memorial Institute for Medical Research, Research Grant of the Princess Takamatsu Cancer Research Fund, and Foundation for Promotion of Cancer Research in Japan.

References

  1. 1.
    Rizvi S, Gores GJ (2013) Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145(6):1215–1229.  https://doi.org/10.1053/j.gastro.2013.10.013CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Malhi H, Gores GJ (2006) Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45(6):856–867.  https://doi.org/10.1016/j.jhep.2006.09.001CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Chan-On W, Nairismagi ML, Ong CK, Lim WK, Dima S, Pairojkul C, Lim KH, McPherson JR, Cutcutache I, Heng HL, Ooi L, Chung A, Chow P, Cheow PC, Lee SY, Choo SP, Tan IB, Duda D, Nastase A, Myint SS, Wong BH, Gan A, Rajasegaran V, Ng CC, Nagarajan S, Jusakul A, Zhang S, Vohra P, Yu W, Huang D, Sithithaworn P, Yongvanit P, Wongkham S, Khuntikeo N, Bhudhisawasdi V, Popescu I, Rozen SG, Tan P, Teh BT (2013) Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat Genet 45(12):1474–1478.  https://doi.org/10.1038/ng.2806CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M, Hama N, Hosoda F, Urushidate T, Ohashi S, Hiraoka N, Ojima H, Shimada K, Okusaka T, Kosuge T, Miyagawa S, Shibata T (2015) Genomic spectra of biliary tract cancer. Nat Genet 47(9):1003–1010.  https://doi.org/10.1038/ng.3375CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Sekiya S, Suzuki A (2012) Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes. J Clin Invest 122(11):3914–3918.  https://doi.org/10.1172/JCI63065CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Fan B, Malato Y, Calvisi DF, Naqvi S, Razumilava N, Ribback S, Gores GJ, Dombrowski F, Evert M, Chen X, Willenbring H (2012) Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest 122(8):2911–2915.  https://doi.org/10.1172/JCI63212CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Dipaola F, Shivakumar P, Pfister J, Walters S, Sabla G, Bezerra JA (2013) Identification of intramural epithelial networks linked to peribiliary glands that express progenitor cell markers and proliferate after injury in mice. Hepatology 58(4):1486–1496.  https://doi.org/10.1002/hep.26485CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Lanzoni G, Cardinale V, Carpino G (2016) The hepatic, biliary, and pancreatic network of stem/progenitor cell niches in humans: a new reference frame for disease and regeneration. Hepatology 64(1):277–286.  https://doi.org/10.1002/hep.28326CrossRefPubMedGoogle Scholar
  9. 9.
    Xu X, Kobayashi S, Qiao W, Li C, Xiao C, Radaeva S, Stiles B, Wang RH, Ohara N, Yoshino T, LeRoith D, Torbenson MS, Gores GJ, Wu H, Gao B, Deng CX (2006) Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest 116(7):1843–1852.  https://doi.org/10.1172/JCI27282CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Ikenoue T, Terakado Y, Nakagawa H, Hikiba Y, Fujii T, Matsubara D, Noguchi R, Zhu C, Yamamoto K, Kudo Y, Asaoka Y, Yamaguchi K, Ijichi H, Tateishi K, Fukushima N, Maeda S, Koike K, Furukawa Y (2016) A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion. Sci Rep 6:23899.  https://doi.org/10.1038/srep23899CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Guest RV, Boulter L, Kendall TJ, Minnis-Lyons SE, Walker R, Wigmore SJ, Sansom OJ, Forbes SJ (2014) Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma. Cancer Res 74(4):1005–1010.  https://doi.org/10.1158/0008-5472.CAN-13-1911CrossRefPubMedGoogle Scholar
  12. 12.
    Nakagawa H, Suzuki N, Hirata Y, Hikiba Y, Hayakawa Y, Kinoshita H, Ihara S, Uchino K, Nishikawa Y, Ijichi H, Otsuka M, Arita J, Sakamoto Y, Hasegawa K, Kokudo N, Tateishi K, Koike K (2017) Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands. Proc Natl Acad Sci U S A 114(19):E3806–E3815.  https://doi.org/10.1073/pnas.1619416114CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Means AL, Xu Y, Zhao A, Ray KC, Gu G (2008) A CK19(CreERT) knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs. Genesis 46(6):318–323.  https://doi.org/10.1002/dvg.20397CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Ijichi H, Chytil A, Gorska AE, Aakre ME, Fujitani Y, Fujitani S, Wright CV, Moses HL (2006) Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes Dev 20(22):3147–3160.  https://doi.org/10.1101/gad.1475506CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Nakagawa H, Hikiba Y, Hirata Y, Font-Burgada J, Sakamoto K, Hayakawa Y, Taniguchi K, Umemura A, Kinoshita H, Sakitani K, Nishikawa Y, Hirano K, Ikenoue T, Ijichi H, Dhar D, Shibata W, Akanuma M, Koike K, Karin M, Maeda S (2014) Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis. Proc Natl Acad Sci U S A 111(3):1090–1095.  https://doi.org/10.1073/pnas.1322731111CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Hayato Nakagawa
    • 1
  • Nobumi Suzuki
    • 1
  • Kazuhiko Koike
    • 1
  1. 1.Department of GastroenterologyThe University of TokyoTokyoJapan

Personalised recommendations